Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/4/15 → 6/4/18 |
Funding
- Chiltern International, Inc. (RB AT PPE 01-13 // RB AT PPE 01-13)
- rEVO Biologics, Inc. (RB AT PPE 01-13 // RB AT PPE 01-13)
Prot # RB AT PPE 01-13:Prospective Randomized Double-Blind, Placebo Controlled Evaluation of the Pharmacokinetics, Safety and Efficacy of Recombinant Antithrombin Versus Placebo in Preterm Preeclampsia (PRESERVE-1) ,
- Grobman, William A (PD/PI)
Project: Research project